Cargando…

Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients

Detalles Bibliográficos
Autores principales:	Maniscalco, Mauro, Fuschillo, Salvatore, Ambrosino, Pasquale, D’Anna, Silvestro Ennio, Accardo, Maria Sofia, Matera, Maria Gabriella, Cazzola, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SEPAR. Published by Elsevier España, S.L.U. 2022
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233876/ https://www.ncbi.nlm.nih.gov/pubmed/34219862 http://dx.doi.org/10.1016/j.arbres.2021.06.004

Ejemplares similares

Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation
por: Maniscalco, Mauro, et al.
Publicado: (2021)

Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients
por: Maniscalco, Mauro, et al.
Publicado: (2021)

Can FeNO be a biomarker in the post-COVID-19 patients monitoring?
por: Maniscalco, Mauro, et al.
Publicado: (2022)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

Is It All about Endothelial Dysfunction? Focusing on the Alteration in Endothelial Integrity as a Key Determinant of Different Pathological Mechanisms
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

Cognitive Impairment in Convalescent COVID-19 Patients Undergoing Multidisciplinary Rehabilitation: The Association with the Clinical and Functional Status
por: Moretta, Pasquale, et al.
Publicado: (2022)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015)

COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings
por: Fuschillo, Salvatore, et al.
Publicado: (2021)

Beyond Dual Bronchodilation – Triple Therapy, When and Why
por: Cazzola, Mario, et al.
Publicado: (2022)

Metabolomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath Condensate
por: Maniscalco, Mauro, et al.
Publicado: (2022)

Performance of fractional exhaled nitric oxide in predicting response to inhaled corticosteroids in chronic cough: a meta-analysis
por: Ambrosino, Pasquale, et al.
Publicado: (2021)

Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
por: Rogliani, Paola, et al.
Publicado: (2017)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019)

Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
por: Matera, Maria Gabriella, et al.
Publicado: (2023)

A Machine Learning Approach to Predict the Rehabilitation Outcome in Convalescent COVID-19 Patients
por: Adamo, Sarah, et al.
Publicado: (2022)

Peripheral Neuropathy in Patients Recovering from Severe COVID-19: A Case Series
por: Balbi, Pietro, et al.
Publicado: (2022)

Cardiopulmonary Exercise Performance and Endothelial Function in Convalescent COVID-19 Patients
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice
por: Mormile, Mauro, et al.
Publicado: (2023)

Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
por: Ambrosino, Pasquale, et al.
Publicado: (2023)

Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

A Rapid Antigen Detection Test to Diagnose SARS-CoV-2 Infection Using Exhaled Breath Condensate by A Modified Inflammacheck(®) Device
por: Maniscalco, Mauro, et al.
Publicado: (2021)

COVID-19 and functional disability: current insights and rehabilitation strategies
por: Ambrosino, Pasquale, et al.
Publicado: (2020)

Cardiac and Pulmonary Rehabilitation: Two Underutilized Approaches with Some Unexpected Benefits
por: Ambrosino, Pasquale, et al.
Publicado: (2023)

Deconditioning in COVID-19 survivors with reduced exercise performance: A role for endothelial dysfunction?
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol
por: Cazzola, Mario, et al.
Publicado: (2013)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
por: Matera, Maria Gabriella, et al.
Publicado: (2016)

Doxofylline is not just another theophylline!
por: Matera, Maria Gabriella, et al.
Publicado: (2017)

Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
por: Cazzola, Mario, et al.
Publicado: (2023)

Endothelial Dysfunction: From a Pathophysiological Mechanism to a Potential Therapeutic Target
por: Ambrosino, Pasquale, et al.
Publicado: (2021)

COVID-19 and Post-Acute COVID-19 Syndrome: From Pathophysiology to Novel Translational Applications
por: Ambrosino, Pasquale, et al.
Publicado: (2021)

Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target
por: Ambrosino, Pasquale, et al.
Publicado: (2022)

Pharmacological treatment and current controversies in COPD
por: Cazzola, Mario, et al.
Publicado: (2019)

Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
por: Cazzola, Mario, et al.
Publicado: (2020)

Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
por: Matera, Maria Gabriella, et al.
Publicado: (2020)

Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients
por: Calzetta, Luigino, et al.
Publicado: (2019)

Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?
por: Perrotta, Fabio, et al.
Publicado: (2020)

Controversy surrounding the Sputnik V vaccine
por: Cazzola, Mario, et al.
Publicado: (2021)

Editorial overview: Respiratory: Pulmonary pharmacology–The emergence of new treatments in pulmonary medicine is finally providing real therapeutic perspectives
por: Cazzola, Mario, et al.
Publicado: (2021)

α(1)-Antitrypsin deficiency and chronic respiratory disorders
por: Cazzola, Mario, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cgm4d9qv1qq8273g2ohj15sdqg